These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 20551110)
1. Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis. Lamas JR; Rodríguez-Rodríguez L; Varadé J; López-Romero P; Tornero-Esteban P; Abasolo L; Urcelay E; Fernández-Gutiérrez B J Rheumatol; 2010 Aug; 37(8):1579-81. PubMed ID: 20551110 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids. de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912 [TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. Jacobsen S; Garred P; Madsen HO; Heegaard NH; Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Smedegaard Andersen L; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Vestergaard A; Østergaard M; Hørslev-Petersen K J Rheumatol; 2009 Apr; 36(4):731-5. PubMed ID: 19273450 [TBL] [Abstract][Full Text] [Related]
4. Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity. Rodríguez-Rodríguez L; Lamas JR; Varadé J; López-Romero P; Tornero-Esteban P; Abasolo L; de la Concha EG; Jover JA; Urcelay E; Fernández-Gutiérrez B Rheumatol Int; 2011 Mar; 31(3):409-13. PubMed ID: 20661738 [TBL] [Abstract][Full Text] [Related]
5. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417 [TBL] [Abstract][Full Text] [Related]
6. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079 [TBL] [Abstract][Full Text] [Related]
7. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139 [TBL] [Abstract][Full Text] [Related]
8. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396 [TBL] [Abstract][Full Text] [Related]
9. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
10. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103 [TBL] [Abstract][Full Text] [Related]
11. sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity. Navarro-Hernández RE; Oregón-Romero E; Rangel-Villalobos H; Vázquez-Del Mercado M; Ruiz-Quezada SL; Maldonado-González M; Torres-Vitela R; Muñoz-Valle JF J Rheumatol; 2006 Oct; 33(10):1968-72. PubMed ID: 17014013 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946 [TBL] [Abstract][Full Text] [Related]
13. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125 [TBL] [Abstract][Full Text] [Related]
14. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477 [TBL] [Abstract][Full Text] [Related]
15. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis]. Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089 [TBL] [Abstract][Full Text] [Related]
16. A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility. Marinou I; Walters K; Winfield J; Bax DE; Wilson AG Ann Rheum Dis; 2010 Jun; 69(6):1191-4. PubMed ID: 19713205 [TBL] [Abstract][Full Text] [Related]
17. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316 [TBL] [Abstract][Full Text] [Related]
18. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221 [TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis. Braun-Moscovici Y; Markovits D; Zinder O; Schapira D; Rozin A; Ehrenburg M; Dain L; Hoffer E; Nahir AM; Balbir-Gurman A J Rheumatol; 2006 Mar; 33(3):497-500. PubMed ID: 16511906 [TBL] [Abstract][Full Text] [Related]
20. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]